Harnessing the full spectrum of digital data to support the delivery of personalised services across the health care continuum: white paper
暂无分享,去创建一个
[1] R. Beger,et al. Metabolomics: a tool for personalizing medicine? , 2008, Personalized medicine.
[2] Peter Mangiafico,et al. Computer vision and image recognition in archaeology , 2019, AIDR.
[3] R. Gordon. An operational classification of disease prevention. , 1983, Public health reports.
[4] Payam Barnaghi,et al. Technology integrated health management for dementia. , 2018, British journal of community nursing.
[5] Arif Khan,et al. Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression , 2018, Int. J. Medical Informatics.
[6] S. Hewner,et al. Aligning population-based care management with chronic disease complexity. , 2014, Nursing outlook.
[7] M. Falster,et al. Overcoming the data drought: exploring general practice in Australia by network analysis of big data , 2018, The Medical journal of Australia.
[8] Subhashini Venugopalan,et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. , 2016, JAMA.
[9] J. Badge. DNA sequencing. , 1998, Methods in molecular biology.
[10] A. C. MacKinney,et al. Care across the continuum: access to health care services in rural America. , 2006, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.
[11] Charles Theillet,et al. What do we learn from HER2-positive breast cancer genomic profiles? , 2010, Breast Cancer Research.
[12] Shirin Enshaeifar,et al. The Internet of Things for Dementia Care , 2018, IEEE Internet Computing.
[13] J. Rasko,et al. Hemophilia B Gene Therapy with a High‐Specific‐Activity Factor IX Variant , 2017, The New England journal of medicine.
[14] I. König,et al. What is precision medicine? , 2017, European Respiratory Journal.
[15] C. Brocker,et al. Improved drug therapy: triangulating phenomics with genomics and metabolomics , 2014, Human Genomics.
[16] R. Beger,et al. Metabolomics as a tool for personalizing medicine: 2012 update. , 2013, Personalized medicine.
[17] Benjamin S. Crosier,et al. Finding a needle in the haystack: Using machine-learning to predict overdose in opioid users , 2017 .
[18] Li Li,et al. Phenome-wide association study using research participants’ self-reported data provides insight into the Th17 and IL-17 pathway , 2017, PloS one.
[19] Jamie R. Robinson,et al. Genome‐wide and Phenome‐wide Approaches to Understand Variable Drug Actions in Electronic Health Records , 2017, Clinical and translational science.
[20] K. Eagar,et al. Examining the high users of hospital resources: implications of a profile developed from Australian health insurance claims data. , 2018, Australian health review : a publication of the Australian Hospital Association.
[21] angesichts der Corona-Pandemie,et al. UPDATE , 1973, The Lancet.
[22] Marlien Varnfield,et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial , 2014, Heart.
[23] Federico Girosi,et al. Analysis of healthcare service utilization after transport-related injuries by a mixture of hidden Markov models , 2018, PloS one.
[24] David Cronkite,et al. Using natural language processing to identify problem usage of prescription opioids , 2015, Int. J. Medical Informatics.
[25] J. F. Springer,et al. THE INSTITUTE OF MEDICINE FRAMEWORK AND ITS IMPLICATION FOR THE ADVANCEMENT OF PREVENTION POLICY , PROGRAMS AND PRACTICE By : , 2007 .
[26] Zhan Ye,et al. Phenome-wide association studies (PheWASs) for functional variants , 2014, European Journal of Human Genetics.
[27] Yuehong Yin,et al. The internet of things in healthcare: An overview , 2016, J. Ind. Inf. Integr..
[28] R. Liberman,et al. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research , 1998 .